Pulse Biosciences, Inc. Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSE

Rank in Stocks #4283
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Share Price
$51.39
Last synced: 2026-10-21
Market Cap
$3.67B
Change (1 day)
1.09%
Change (1 year)
197.94%
Country
US
Trade Pulse Biosciences, Inc. (PLSE)

Category

Healthcare
Stock split history for Pulse Biosciences, Inc. (PLSE)
Pulse Biosciences, Inc. stock (symbol: PLSE) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 22, 2026.
One PLSE share bought prior to Oct 22, 2026 would equal to 0 PLSE shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH